PBLS · Parabilis Medicines, Inc. · Executive Compensation
$29.79
+0.54 (+1.85%)
At close · Nov 4
Return incl. dividend (before tax)
Market Cap
$3.70B
Shares
123.53M
Volume · Nov 4
501.62K
Avg daily vol (3M)
887.95K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Craig Tendler | director | Appointed | 2026-08-25 |
Leadership
- Craig Tendler Board Member
Key facts
CIK
1657677
CUSIP
698955101
13F (30d)
17 filings
17 filers
Visit website
Investor relations